IL1B and melanoma: Metastatic NSCLC, colorectal cancer and melanoma samples also show increased IL-1 transcript levels [22], and in glioma stem-like cells prolonged IL-1β exposure promotes tumour progression via COX-2–mediated oxidative DNA damage and disruption of p53 tumour-suppressor activity [26].